In 2018, He et al showed that upregulation of miR-592 can promote proliferation, migration, and invasion in gastric cancer, and induces the epithelial-mesenchymal transition (EMT) through the PI3K/AKT and MAPK/ERK signaling pathways by inhibiting Spry2 [10]. The gene discussed is SPRY2; the disease is gastric cancer.